These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28885482)

  • 1. Comparison of Localized and Systemic Otitis Media With ANCA-Associated Vasculitis.
    Okada M; Suemori K; Takagi D; Teraoka M; Yamada H; Hato N
    Otol Neurotol; 2017 Dec; 38(10):e506-e510. PubMed ID: 28885482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.
    Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Okada M; Kunimoto Y; Watanabe T; Inagaki A; Yoshida T; Imaizumi M; Nakamura T; Matsunobu T; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
    Auris Nasus Larynx; 2021 Feb; 48(1):2-14. PubMed ID: 32768313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in Japan.
    Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Kunimoto Y; Matsui T; Sakaguchi H; Okada M; Watanabe T; Inagaki A; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
    Mod Rheumatol; 2017 Jan; 27(1):87-94. PubMed ID: 27166750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis.
    Yoshida N; Iino Y
    Allergol Int; 2014 Dec; 63(4):523-32. PubMed ID: 25339433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between ear involvement and clinical features and prognosis in ANCA-associated vasculitis.
    Hosokawa Y; Okada M; Suemori K; Hamaguchi N; Miyoshi KI; Takagi T; Teraoka M; Yamada H; Ishizaki J; Matsumoto T; Hato N
    Auris Nasus Larynx; 2021 Oct; 48(5):885-889. PubMed ID: 33589280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hearing prognosis of otitis media with ANCA-associated vasculitis.
    Iwata S; Okada M; Suemori K; Teraoka M; Yamada H; Ishizaki J; Matsumoto T; Hato N
    Auris Nasus Larynx; 2021 Jun; 48(3):377-382. PubMed ID: 32951931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vestibular Involvement in Patients With Otitis Media With Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Morita Y; Takahashi K; Izumi S; Kubota Y; Ohshima S; Horii A
    Otol Neurotol; 2017 Jan; 38(1):97-101. PubMed ID: 27749752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tympanic membrane findings of otitis media with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV).
    Morita Y; Kitazawa M; Yagi C; Nonomura Y; Takahashi K; Yamagishi T; Ohshima S; Izumi S; Horii A
    Auris Nasus Larynx; 2020 Oct; 47(5):740-746. PubMed ID: 32173171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cochlear implantation in patients with bilateral deafness caused by otitis media with ANCA-associated　vasculitis (OMAAV): A report of four cases.
    Watanabe T; Yoshida H; Kishibe K; Morita Y; Yoshida N; Takahashi H; Harabuchi Y
    Auris Nasus Larynx; 2018 Oct; 45(5):922-928. PubMed ID: 29807863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment outcomes of rituximab for intractable otitis media with ANCA-associated vasculitis.
    Okada M; Suemori K; Takagi D; Teraoka M; Yamada H; Ishizaki J; Matsumoto T; Hasegawa H; Hato N
    Auris Nasus Larynx; 2019 Feb; 46(1):38-42. PubMed ID: 29885746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intractable otitis media - Pathogenesis and treatment of Eosinophilic otitis media (EOM) and otitis media with Antineutrophil cytoplasmic antibody (ANCA) -associated vasculitis (OMAAV).
    Yoshida N
    Auris Nasus Larynx; 2023 Apr; 50(2):171-179. PubMed ID: 35934599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Otitis media with ANCA-associated vasculitis: A retrospective study of 30 patients.
    Tabei A; Sakairi T; Ohishi Y; Watanabe M; Nakasatomi M; Hamatani H; Ikeuchi H; Kaneko Y; Hiromura K
    Mod Rheumatol; 2022 Aug; 32(5):923-929. PubMed ID: 34915561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Otologic Manifestations in Patients with ANCA Associated Vasculitis-Comparative Analysis among Microscopic Polyangiitis, Granulomatosis with Polyangiitis and Eosinophilic Granulomatosis with Polyangiitis].
    Kawashima Y; Noguchi Y; Ito T; Mizushima K; Takahashi M; Kitamura K; Tsutsumi T
    Nihon Jibiinkoka Gakkai Kaiho; 2016 Feb; 119(2):110-7. PubMed ID: 27149708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Otitis Media with ANCA-associated Vasculitis: A New Concept and the Associated Criteria.
    Kobari Y; Nagasawa T
    Intern Med; 2017 Dec; 56(24):3365-3367. PubMed ID: 29021451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serological Study of Otitis Media with ANCA Associated Vasculitis (OMAAV)].
    Tateyama K; Kodama S; Nomi N; Suzuki M; Kishibe K; Harabuchi Y
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Sep; 118(9):1133-42. PubMed ID: 26615664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Quantification of Extracellular Trap Cell Death-Derived Products as Diagnostic Biomarkers for Otitis Media With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Eosinophilic Otitis Media.
    Morita S; Nakamaru Y; Fukuda A; Fujiwara K; Suzuki M; Hoshino K; Honma A; Homma A
    Otol Neurotol; 2022 Mar; 43(3):e337-e343. PubMed ID: 34802016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging characteristics of hypertrophic pachymeningitis due to ANCA-associated vasculitis.
    Takagi T; Okada M; Nakamura M; Hanari T; Nakata T; Teraoka M; Hato N
    Auris Nasus Larynx; 2022 Oct; 49(5):875-879. PubMed ID: 35074241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Diagnostic and Clinical Utility of the Myeloperoxidase-DNA Complex as a Biomarker in Otitis Media With Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Morita S; Nakamaru Y; Nakazawa D; Suzuki M; Hoshino K; Fukuda A; Hattanda F; Kusunoki K; Tomaru U; Ishizu A; Homma A
    Otol Neurotol; 2019 Feb; 40(2):e99-e106. PubMed ID: 30570611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of and Prognosis for Facial Palsy in Patients With Otitis Media With ANCA-Associated Vasculitis (OMAAV).
    Fujiwara K; Morita S; Fukuda A; Yanagi H; Hoshino K; Nakamaru Y; Furuta Y; Homma A
    Otol Neurotol; 2021 Dec; 42(10):e1577-e1582. PubMed ID: 34353982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labyrinthine calcification in ears with otitis media and antineutrophil cytoplasmic antibody-associated vasculitis (OMAAV): A report of two cases.
    Yoshida T; Kobayashi M; Sugimoto S; Naganawa S; Sone M
    Auris Nasus Larynx; 2023 Apr; 50(2):299-304. PubMed ID: 35058072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.